May saw a drug ad spending slump across the majority of the top ten drug ad spenders with AbbVie’s Skyrizi and RInvoq, Johnson & Johnson’s Tremfya and more all decreasing their monthly TV ad spend.

Subscribe for Updates

Copyright 2025 dijee Intelligence Ltd.   dijee Intelligence Ltd. is a private limited company registered in England and Wales at Media House, Sopers Road, Cuffley, Hertfordshire, EN6 4RY, UK registration number 16808844